Access the world's trusted COVID-19 data today
Coverage
Solutions for
Products
Newsroom
About
Contact us

Predictive science intelligence

New science is the engine of progress. Airfinity is the tool to unlock the future.
Trusted by
hm-government-vector-logo
Featured in more than 200 newspapers, journals and on TV networks worldwide

Airfinity provides real time life science intelligence as a subscription service

  • Therapy area relevant information in one easy-to-navigate platform updated multiple times daily
  • In depth forecasts, insights and meta-science briefings
  • A daily curated newsletter and hotline access to therapy specialised analysts

Why Airfinity

First

We collect data from the earliest sources which allows us to provide decision makers with the most up-to-date comprehensive and granular intelligence on critical new scientific developments in real-time.

Predictive

By turning millions of fragmented science-related data points into a structured data set we build dynamic forecasts models and simulations for trial readouts, approval likelihood, production, pricing and more to provide better decision making tools.

Accurate

All information is classified and analysed by specialised experts ensuring the highest standards and quality. Our analyst team consist of some of the most talented scientists of their generation, top KOLs and industry veterans. We are fiercely independent and data driven.

How we do it

Daily compound-centric analysis

We monitor thousands of sources in all major languages to have a molecular or disease centric view and set of impact metrics. All preclinical and clinical compounds covered.

Database access to disease prevalence, production, supply & funding

Though public sources and data partnerships, we collect unstructured signals on production, supply, deals, infections, government and company level policies.

Dynamic simulations

Our forecast models for trial read outs, production and immunisations are updated as new information is available. We can integrate with our clients’ own data streams to create custom predictors.

Sign up to receive a weekly sample of our insights

Free for 3 months for verified organisations only.

To schedule a demo today, contact us. To receive our media briefings, email press@airfinity.com.

Who we serve

Asset Managers & Banks

Identify alpha rich investment opportunities with deep analysis of new scientific trends, players and technologies impacting the industry’s value chain.

Governments & Healthcare Authorities

Monitor new science to inform national biosecurity strategies, funding allocations and procurement decisions across defence, health and science ministries.

International Organisations & NGOs

Make data driven funding and strategic decisions on emerging therapeutics to improve disease response and horizon scan the broader new science landscape.

Medtech

Get structured predictive industry, competitor and scientific intelligence to inform key decisions across the life cycle and empower your go-to-market strategy.

Multi-nationals

Manage your infectious disease risk. Access country level forecasts of disease prevalence with an overview of treatments and vaccines. Combine our intelligence with your own data on workforce demographics and supply chains to act in time to protect employee health and avoid disruptions.

Pharma & Biotech

Get structured, predictive market and scientific intelligence to inform key decisions across the life cycle from R&D, supply through medical affairs to commercial.

Research institutions

Enrich academic research and analysis with access to a real time, comprehensive and structured data set covering all new scientific developments in a given therapy area.

In the news

Apr
14

Rare side effects cast cloud over vaccines much of the world desperately needs

Published by The Washington Post

Coverage

Copyright © Airfinity Limited 2021.
Privacy Policy